Editas Medicine Vs. Regenxbio Industry Stock Comparison

Sell

22

EDIT
Editas Medicine

Last Price:

$1.33

Seasonality Move:

-11.28%

Sell

9

RGNX
Regenxbio

Last Price:

$7.65

Seasonality Move:

-8.12%

Sell

22

Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

9

Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

The current Regenxbio [RGNX] share price is $7.63. The Score for RGNX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
RGNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

The Editas Medicine share price today is $1.31

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

The Regenxbio share price today is $7.63

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.36	Sell
Relative Strength Index (14 RSI):	23.89	Sell
Chaikin Money Flow:	-1676224	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.63 - 2.43)	Sell
Bollinger Bands (100):	(2.37 - 4.05)	Sell

RGNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.55	Sell
Relative Strength Index (14 RSI):	36.19	Sell
Chaikin Money Flow:	5857711	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.41 - 9.97)	Sell
Bollinger Bands (100):	(9.16 - 12.08)	Sell

EDIT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.54	Sell
20-day SMA:	1.92	Sell
50-day SMA:	2.6	Sell
200-day SMA:	4.58	Sell
8-day EMA:	1.53	Sell
20-day EMA:	1.88	Sell
50-day EMA:	2.47	Sell
200-day EMA:	4.44	Sell

RGNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.27	Sell
20-day SMA:	9.07	Sell
50-day SMA:	9.56	Sell
200-day SMA:	13.31	Sell
8-day EMA:	8.2	Sell
20-day EMA:	8.85	Sell
50-day EMA:	9.58	Sell
200-day EMA:	12.46	Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Editas Medicine Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):